This article describes a new Stata command called simontwostage, which calculates the critical values and sample sizes for two-stage designs for phase II oncology trials. Options are provided to determine the minimax and optimal designs proposed by Simon (1989, Controlled Clinical Trials 10: 1–10) and admissible designs described by Jung et al. (2004, Statistics in Medicine 23: 561–569). Furthermore, nonstochastic and stochastic curtailment rules can be implemented in both stages of the trial, and the properties of the curtailed designs can be examined
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...
Phase II clinical trials in oncology are used for initial evaluation of the therapeutic efficacy of ...
Phase II oncology trials are conducted to evaluate whether the tumour activity of a new treatment is...
This article describes a new Stata command called simontwostage, which calculates the critical value...
This article describes a new Stata command called simontwostage, which calculates the critical value...
AbstractThe Simon two-stage optimal design is often used for phase II cancer clinical trials. A stud...
Two-stage designs that allow for early stopping if the treatment is ineffective are commonly used in...
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regim...
The Simon two-stage optimal design is often used for phase II cancer clinical trials. A study procee...
Background: For most cytotoxic and biologic anti-cancer agents, the response rate of the drug is com...
Randomised controlled trials are considered the gold standard in trial design. However, phase II onc...
Optimal two-stage randomized phase 11 clinical trials Brent R Logan Randomized phase 11 clinical tri...
Phase II clinical trials are a critical aspect of the drug development process. With drug developmen...
In Phase II oncology trials, therapies are increasingly being evaluated for their effectiveness in s...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...
Phase II clinical trials in oncology are used for initial evaluation of the therapeutic efficacy of ...
Phase II oncology trials are conducted to evaluate whether the tumour activity of a new treatment is...
This article describes a new Stata command called simontwostage, which calculates the critical value...
This article describes a new Stata command called simontwostage, which calculates the critical value...
AbstractThe Simon two-stage optimal design is often used for phase II cancer clinical trials. A stud...
Two-stage designs that allow for early stopping if the treatment is ineffective are commonly used in...
Objectives: In phase II clinical trials in oncology, the potential efficacy of a new treatment regim...
The Simon two-stage optimal design is often used for phase II cancer clinical trials. A study procee...
Background: For most cytotoxic and biologic anti-cancer agents, the response rate of the drug is com...
Randomised controlled trials are considered the gold standard in trial design. However, phase II onc...
Optimal two-stage randomized phase 11 clinical trials Brent R Logan Randomized phase 11 clinical tri...
Phase II clinical trials are a critical aspect of the drug development process. With drug developmen...
In Phase II oncology trials, therapies are increasingly being evaluated for their effectiveness in s...
In phase II clinical trials on cancer, it is of great interest to establish the efficacy and safety ...
The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it ...
Phase II clinical trials in oncology are used for initial evaluation of the therapeutic efficacy of ...
Phase II oncology trials are conducted to evaluate whether the tumour activity of a new treatment is...